V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036680 | 210008218 | null | 43.5 | Curative (C) | 2016-11-22 | 2017-07-20 | CNS Headstart II A Ind 4,5 int | 02 | N | 210014933 | NOT MATCHED |
| 210036681 | 210008221 | 0 | 10 | Curative (C) | 2015-05-31 | 2015-07-07 | CNS High Grade Glioma PCV | N | N | 210014955 | NOT MATCHED |
| 210036682 | 210008231 | 0 | 9.1 | Curative (C) | 2016-06-17 | 2017-01-03 | null | N | N | 210014963 | NOT MATCHED |
| 210036683 | 210008245 | 0 | 98 | Curative (C) | 2018-10-11 | 2018-12-24 | CNS High Grade Glioma PCV | 01 | N | 210015020 | NOT MATCHED |
| 210036684 | 210026402 | null | 10.3 | Curative (C) | 2013-04-12 | 2014-02-27 | CNS PNET 5 Medbl L/StRsk Mnt A Carb | Y | N | 210015041 | NOT MATCHED |
| 210036685 | 210008264 | null | 14.5 | Curative (C) | 2014-03-31 | 2014-06-09 | CNS Epen2007 09 Baby Brn vinc+Mtx | N | N | 210015067 | NOT MATCHED |
| 210036686 | 210008269 | null | 81.4 | Disease modification (D) | null | 2014-06-05 | CNS Medbl HR Maint vinc+ Lomustine | 02 | N | 210015070 | NOT MATCHED |
| 210036687 | 210008275 | 0 | null | Curative (C) | 2014-11-07 | 2014-11-08 | CNS LGG 2004 03 cons vinc + carbo | N | N | 210015090 | NOT MATCHED |
| 210036688 | 210008284 | null | 21.5 | Curative (C) | 2013-06-08 | 2013-12-20 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | N | N | 210015114 | NOT MATCHED |
| 210036689 | 210019312 | 0.94 | null | Adjuvant (A) | 2015-05-07 | 2015-08-25 | CNS Medbl HR Vinc + Carbo | N | N | 210015133 | NOT MATCHED |
| 210036690 | 210008294 | null | null | Curative (C) | null | 2014-11-08 | ALL Ph+ve Das1st/2nd Rind IIA Pasp | null | N | 210015141 | NOT MATCHED |
| 210036691 | 210008301 | 0 | 66.4 | Palliative (P) | 2018-10-16 | 2019-02-25 | CNS Headstart II Myeloablation | N | N | 210015173 | NOT MATCHED |
| 210036692 | 210008307 | null | 84.5 | Curative (C) | 2015-07-10 | 2016-03-27 | CNS PNET 5 Medbl L/StRsk Mnt B | N | N | 210015192 | NOT MATCHED |
| 210036693 | 210008314 | 1.2 | 6.4 | Disease modification (D) | 2015-11-02 | 2015-11-02 | CNS Medbl HR Etoposide | N | N | 210015202 | NOT MATCHED |
| 210036694 | 210008317 | null | 17.9 | Curative (C) | 2016-02-20 | 2016-03-17 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | Y | null | 210015206 | NOT MATCHED |
| 210036695 | 210008323 | 0 | 103.7 | Curative (C) | 2016-05-15 | 2016-11-13 | CNS Headstart II A Ind 1,2,3 int | null | N | 210015216 | NOT MATCHED |
| 210036696 | 210008331 | null | 13.3 | Curative (C) | 2015-01-31 | 2015-05-23 | CNS Ependymoma II Vinc/Cyclophos | 02 | N | 210015220 | NOT MATCHED |
| 210036697 | 210008338 | 0.95 | 15.2 | Curative (C) | 2015-06-06 | 2015-06-19 | CNS Medullo HR Cis/Vinc/Cyclo + PBSCR | 2 | N | 210015224 | NOT MATCHED |
| 210036698 | 210008355 | 0 | 23.6 | Curative (C) | 2018-05-25 | 2018-05-25 | CNS Ependy II Cisplatin + valproate | N | N | 210015258 | NOT MATCHED |
| 210036699 | 210008361 | 0 | 10.3 | Curative (C) | 2016-01-11 | 2016-01-17 | ALL Interfant 06 Protocol 1B | N | N | 210015268 | NOT MATCHED |
| 210036700 | 210008367 | null | 89 | Curative (C) | 2018-01-23 | 2018-01-30 | ALL UKALL2011 Del Intens A Pt2 | N | null | 210015285 | NOT MATCHED |
| 210036701 | 210008382 | 1.19 | 16.7 | null | 2017-01-28 | 2017-02-04 | ALL ALLR3: S/IR Con Wk6 (PAsp)HDMTx | Y | N | 210015310 | NOT MATCHED |
| 210036702 | 210008397 | null | 9.7 | Palliative (P) | 2015-05-27 | 2015-06-21 | ALL Ph+ve Imatinib - ConsHR1 Pasp | 02 | N | 210015323 | NOT MATCHED |
| 210036704 | 210008448 | null | 105 | Palliative (P) | 2016-04-20 | 2016-04-26 | PCV | 02 | N | 210015447 | PCV |
| 210036705 | 210008450 | 1.81 | 77.7 | Curative (C) | 2017-03-31 | 2017-04-08 | PCV | 2 | N | 210015451 | PCV |
| 210036706 | 210008461 | 1.56 | 79.8 | Palliative (P) | 2013-11-06 | 2013-11-06 | PCV | N | N | 210015471 | PCV |
| 210036707 | 210008465 | 1.7 | 59 | Palliative (P) | 2016-02-07 | 2016-05-19 | PCV | null | null | 210015472 | PCV |
| 210036708 | 210019371 | null | null | Palliative (P) | 2017-03-04 | 2017-03-07 | PCV | null | null | 210015487 | PCV |
| 210036709 | 210008498 | 1.68 | 60.9 | Curative (C) | 2018-09-24 | 2018-10-09 | PCV | N | null | 210015535 | PCV |
| 210036710 | 210008516 | 1.5 | 80.85 | Palliative (P) | 2017-05-21 | 2017-05-22 | PCV | N | N | 210015606 | PCV |
| 210036711 | 210008520 | 1.6 | 76.6 | Palliative (P) | 2014-05-13 | 2014-05-18 | PCV | N | N | 210015612 | PCV |
| 210036712 | 210008524 | 1.78 | 78 | Curative (C) | 2018-05-25 | 2018-06-24 | PCV | 2 | N | 210015620 | PCV |
| 210036713 | 210008528 | 1.77 | 66.5 | Adjuvant (A) | null | 2016-07-28 | Temozolomide + RT | N | N | 210015630 | TEMOZOLOMIDE + RT |
| 210036714 | 210008533 | 1.6 | 91.1 | Unknown (U) | 2017-09-02 | 2018-02-18 | Trial Unspecified | N | N | 210015631 | TRIAL |
| 210036715 | 210008539 | null | null | Adjuvant (A) | 2017-03-04 | 2017-03-09 | Temozolomide + RT | N | null | 210015667 | TEMOZOLOMIDE + RT |
| 210036716 | 210008544 | 0 | 85.6 | Adjuvant (A) | 2017-09-25 | 2017-10-24 | Temozolomide + RT | N | null | 210015677 | TEMOZOLOMIDE + RT |
| 210036717 | 210008557 | 1.75 | 89 | Curative (C) | 2017-12-10 | 2017-12-23 | Temozolomide + RT | N | Y | 210015705 | TEMOZOLOMIDE + RT |
| 210036718 | 210008563 | 1.66 | 81.8 | Not known (9) | 2017-11-14 | 2017-12-05 | Temozolomide + RT | N | N | 210015709 | TEMOZOLOMIDE + RT |
| 210036720 | 210008594 | 1.67 | 19.25 | Curative (C) | 2018-08-08 | 2018-08-17 | Trial Unspecified | Y | Y | 210015782 | TRIAL |
| 210036721 | 210008600 | 1.75 | null | Palliative (P) | 2017-06-15 | 2017-07-06 | Temozolomide + RT | N | null | 210015788 | TEMOZOLOMIDE + RT |
| 210036722 | 210008609 | 1.68 | 16.3 | Curative (C) | 2015-02-26 | 2015-11-07 | Trial Unspecified | Y | Y | 210015802 | TRIAL |
| 210036723 | 210008614 | 1.77 | 47 | Disease modification (D) | 2016-09-05 | 2017-02-27 | Trial Unspecified | 01 | Y | 210015816 | TRIAL |
| 210036725 | 210008635 | 1.79 | null | Curative (C) | 2018-06-03 | 2018-06-23 | Temozolomide + RT | N | N | 210015892 | TEMOZOLOMIDE + RT |
| 210036726 | 210008643 | 0 | 70.95 | null | 2015-04-16 | 2015-05-25 | Temozolomide + RT | N | N | 210015905 | TEMOZOLOMIDE + RT |
| 210036727 | 210008656 | 1.68 | 20.6 | Palliative (P) | 2016-10-07 | 2017-02-28 | Trial Unspecified | 1 | null | 210015978 | TRIAL |
| 210036728 | 210008670 | 1.76 | 89.7 | Curative (C) | 2016-04-18 | 2016-04-19 | CNS Medbl HR Cyclo+Vinc | N | N | 210016088 | TRIAL |
| 210036729 | 210008676 | 1.19 | 70.9 | Curative (C) | 2016-08-22 | 2016-09-08 | Temozolomide + RT | N | null | 210016120 | TEMOZOLOMIDE + RT |
| 210036730 | 210019493 | 1.82 | 95.7 | Unknown (U) | 2015-10-27 | 2015-10-27 | Trial Unspecified | 01 | N | 210016143 | TRIAL |
| 210036731 | 210019502 | 1.86 | null | Disease modification (D) | 2014-01-09 | 2014-03-21 | Temozolomide + RT | N | N | 210016177 | TEMOZOLOMIDE + RT |
| 210036732 | 210008697 | 1.59 | 76.6 | Palliative (P) | 2015-08-23 | 2015-08-23 | Trial Unspecified | Y | N | 210016180 | TRIAL |